27 March 2015
Guscio PLC
("Guscio" or the "Company" or the "Group")
Issue of Equity
The Company announces that, following the exercise of warrants earlier today,
it has issued and allotted 169,491 ordinary shares of 0.1 pence each in the
capital of the Company ("Ordinary Shares") at a subscription price of 2.95
pence per share ("New Ordinary Shares").
The Company has made application for the New Ordinary Shares to be admitted to
trading on AIM. It is expected that admission will become effective on 2 April
2015 ("Admission").
Following the issue of the New Ordinary Shares, and for the purposes of the
Disclosure and Transparency Rules, the Company's total issued share capital on
Admission will consist of 16,028,471 Ordinary Shares.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company, under the
Disclosure and Transparency Rules.
FOR FURTHER INFORMATION, PLEASE CONTACT:
Guscio PLC
Tony Humphreys / Marcus Yeoman 0203 053 1897
Sanlam Securities UK Limited
Virginia Bull / Simon Clements 020 7628 2200
Peterhouse Corporate Finance Limited
Lucy Williams / Eran Zucker 020 7469 0936
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.